OPKO Health (Canada)

Recent papers from OPKO Health (Canada)

1. Factors Affecting Self-Reported Facial Protective Equipment Adherence by Rehabilitation Providers in Home Care During the SARS-CoV-2 Pandemic: A Cross-Sectional Pilot StudyHome Health Care Management & Practice · 2026
2. Home Health Care Providers' Readiness to Care for Children and Youth With Complex Medical Conditions: A Scoping ReviewJournal of Paediatrics and Child Health · 2026
3. OR21-04 Long-term Efficacy And Safety Of Once-weekly Somatrogon In Pediatric Subjects With Growth Hormone Deficiency: Results From Up To 8 Years Of Somatrogon TreatmentJournal of the Endocrine Society · 2023
4. An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatmentJournal of Pediatric Endocrinology and Metabolism · 2023
5. Menstrual cycle-associated symptoms and workplace productivity in US employees: a cross-sectional survey of users of the Flo mobile phone app2022
6. Home care providers' perceptions of shared decision‐making with older clients (and their caregivers): A cross‐sectional studyNursing and Health Sciences · 2022
7. Person‐ and family‐centred goal‐setting for older adults in Canadian home care: A solution‐focused approachHealth & Social Care in the Community · 2021
8. Switch Data From the Open-Label Extension of the Pivotal Phase 3 Study of Once Weekly Somatrogon Compared to Daily Somatropin in Pediatric Patients With Growth Hormone Deficiency (pGHD)Journal of the Endocrine Society · 2021
9. Phase 3 Study Evaluating Once Weekly Somatrogon Compared to Daily Genotropin in Japanese Patients With Pediatric Growth Hormone Deficiency (pGHD)Journal of the Endocrine Society · 2021
10. Results From an Open-Label Extension of the Phase 2 Dose Finding Study of Once Weekly Somatrogon vs Daily Genotropin in Pediatric Patients With Growth Hormone Deficiency (GHD)Journal of the Endocrine Society · 2021
11. Characterization of Polycystic Ovary Syndrome Among Flo App Users Around the World2020
12. Gastrin analogue administration adds no significant glycaemic benefit to a glucagon‐like peptide‐1 receptor agonist acutely or after washout of both analoguesDiabetes Obesity and Metabolism · 2019
13. CIHR Health System Impact Fellows: Reflections on "Driving Change" Within the Health SystemInternational Journal of Health Policy and Management · 2018
14. Randomised controlled trial comparing marksmanship following application of a tourniquet or haemostatic clamp in healthy volunteersJournal of the Royal Army Medical Corps · 2016
15. Oral peptide specific egg antibody to intestinal sodium-dependent phosphate co-transporter-2b is effective at altering phosphate transport in vitro and in vivoPoultry Science · 2015
16. Reliability of the Thoracolumbar Injury Classification and Severity Score and Comparison With the Denis Classification for Injury to the Thoracic and Lumbar SpineSpine · 2012